Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction: A Multicenter Randomized Controlled Trial

NCT07252401 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.

NCT NCT07252401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07252401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction: A Multicenter Randomized Controlled Trial
Lead sponsor
General Hospital of Shenyang Military Region
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 25, 2026
Completion date
March 31, 2028
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis